title: Role of MRI in the diagnosis and management of prostate cancer.
abstract: Multiparametric MRI of the prostate consists of T1- and T2-weighted sequences, which provide anatomical information, and one or more 'functional' sequences, that is, diffusion-weighted imaging, dynamic contrast-enhanced sequences and magnetic resonance spectroscopy. Prostate MRI is the most accurate imaging method for local staging of prostate cancer and can also be used for the noninvasive evaluation of tumor aggressiveness. By magnetic resonance-guided prostate biopsy it is possible to target the most cancer-suspicious areas of the gland, especially in patients with a negative transrectal biopsy. In patients with biochemical recurrence after radical treatment, MRI is a valuable tool for the detection of local tumor recurrence and whole-body MRI can be used for the diagnosis of distant metastases.
authors.affiliation: Memorial Sloan Kettering Cancer Center, Department of Radiology, 1275 York Avenue, New York City, NY 10065, USA.
authors.forename: Andreas G
authors.initials: AG
authors.lastname: Wibmer
authors.affiliation: Memorial Sloan Kettering Cancer Center, Department of Radiology, 1275 York Avenue, New York City, NY 10065, USA.
authors.forename: Hebert Alberto
authors.initials: HA
authors.lastname: Vargas
authors.affiliation: Memorial Sloan Kettering Cancer Center, Department of Radiology, 1275 York Avenue, New York City, NY 10065, USA.
authors.forename: Hedvig
authors.initials: H
authors.lastname: Hricak
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis*
keywords: MRI; cancer detection; cancer recurrence; cancer staging; prostate cancer; risk assessment; whole-body MRI